Skip to content

Clinical application of three-dimensional preoperative planning in spinal degenerative diseases

Clinical application of three-dimensional preoperative planning in spinal degenerative diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065485
Enrollment
Unknown
Registered
2022-11-07
Start date
2022-11-15
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative degeneration of the spine

Interventions

3D Planning Group:3D Planning
General Planning Group:General Planning

Sponsors

The Second Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with cervical spondylosis, lumbar disc protrusion, spinal stenosis and other degenerative diseases of the spine caused by daily activities disorders, after conservative treatment ineffective surgery; 2. American Society of Anesthesiologists (ASA) classification: I-II; 3. Informed and consented to the treatment and trial protocol; 4. Complete imaging data; 5. They can communicate with each other in normal language.

Exclusion criteria

Exclusion criteria: 1. Patients with serious underlying diseases or other diseases affecting the questionnaire evaluation; 2. Incomplete clinical data; 3. Incomplete follow-up data; 4. Combined with hip, knee, ankle joint diseases and surgical history.

Design outcomes

Primary

MeasureTime frame
radiography;Pain score;Clinical score;Function scores;Stress analysis;Drug utilization;LOS (length of stay);Time of operation;Blood loss volume;Postoperative complications;Satisfaction;

Countries

China

Contacts

Public ContactWang Lichun

The Second Affiliated Hospital of Harbin Medical University

wlcbox@sina.com+86 13836027717

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026